LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 513 | 2415 | 10386 | 0.2325 | 0.4289 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 513 | 2986 | 10494 | 0.2845 | 0.4985 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 513 | 3211 | 10537 | 0.3047 | 0.5228 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 513 | 2390 | 10386 | 0.2301 | 0.4255 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 513 | 3549 | 10494 | 0.3382 | 0.5591 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 513 | 2634 | 10537 | 0.2500 | 0.4552 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 513 | 2311 | 10386 | 0.2225 | 0.4145 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 513 | 2651 | 10494 | 0.2526 | 0.4581 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 513 | 2321 | 10537 | 0.2203 | 0.4135 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 513 | 1709 | 10386 | 0.1645 | 0.3194 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 513 | 2057 | 10494 | 0.1960 | 0.3755 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 513 | 2445 | 10537 | 0.2320 | 0.4305 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 513 | 2220 | 10386 | 0.2137 | 0.4014 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 513 | 1963 | 10494 | 0.1871 | 0.3608 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 513 | 2872 | 10537 | 0.2725 | 0.4843 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 513 | 2377 | 10386 | 0.2289 | 0.4237 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 513 | 2804 | 10494 | 0.2672 | 0.4770 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 513 | 8424 | 10254 | 0.8215 | 0.9110 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 513 | 8109 | 10349 | 0.7835 | 0.8905 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 513 | 8511 | 10483 | 0.8118 | 0.9065 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 513 | 7575 | 10254 | 0.7387 | 0.8646 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 513 | 7174 | 10349 | 0.6932 | 0.8378 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 513 | 6514 | 10483 | 0.6214 | 0.7929 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 513 | 4509 | 10254 | 0.4397 | 0.6536 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 513 | 4967 | 10349 | 0.4799 | 0.6883 |